Glancy prongay & murray llp, a leading securities fraud law firm, announces the filing of a securities class action on behalf of nrx pharmaceuticals, inc. (nrxp) investors

Los angeles--(business wire)--glancy prongay & murray llp (“gpm”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired nrx pharmaceuticals, inc. (“nrx” or the “company”) (nasdaq: nrxp) securities between june 1, 2021 and november 4, 2021, inclusive (the “class period”). nrx investors have until march 21, 2022 to file a lead plaintiff motion. if you suffered a loss on your nrx investme
NRXP Ratings Summary
NRXP Quant Ranking